Edit

drug discovery

21 July 2021 Proteasome targeting unwanted proteins.

The PROTACtable genome – a new route to drug discovery

29 April 2021 Vials containing protein crystals stored in a round ‘puck’

EMBL provides key infrastructure for COVID-19 drug screening project

9 April 2021 ChEMBL used for COVID-19 drug discovery

Repurposing drugs to manage COVID-19 progression

15 October 2020 Four blue circular objects are surrounded with green structures, and the central blue circle with pink structures. The blue circles are human cell nuclei, and pink and green structures are proteins.

Four blue circular objects are surrounded with green structures, and the central blue circle with pink structures. The blue circles are human cell nuclei, and pink and green structures are proteins.

Repurposing drugs for a pan-coronavirus treatment

8 July 2020

Artwort illustrating various aspects of infection research. The centre of the image shows a cartoon representation of a coronavirus. The spheric shape has been overlaid with a map of the world to illustrate the global spread of viruses. The edges of the artwork feature images of potential virus hosts (bats, poultry, dromedary), a group of humans, a microscope, pills, a syringe and vaccine vial, protein structures, and an illustration of a human lung. The background is set in yellow and red colour.

What COVID-19 is teaching us

1 July 2020 New Informatics Science Director at Open Targets, Ellie McDonagh

Welcome: Ellie McDonagh

29 April 2020

Understanding the influenza virus

17 June 2019 A photo of the Hamburg harbour at dusk

EMBL and Tara: Hamburg

10 April 2019

Prioritising cancer drug targets using CRISPR

23 January 2019 New Open Targets Director, Ian Dunham in EMBL-EBI South Building

New Open Targets Director appointed

30 October 2018 Sanofi logo on blue background

Sanofi joins Open Targets

20 September 2018

Promega joins EMBL’s Corporate Partnership Programme

EMBLetc.

Read the latest Issues of our magazine - EMBLetc.

Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.

EMBLetc. archive

Edit

drug discovery

The PROTACtable genome – a new route to drug discovery

EMBL provides key infrastructure for COVID-19 drug screening project

Repurposing drugs to manage COVID-19 progression

Repurposing drugs for a pan-coronavirus treatment

What COVID-19 is teaching us

Welcome: Ellie McDonagh

Understanding the influenza virus

EMBL and Tara: Hamburg

Prioritising cancer drug targets using CRISPR

New Open Targets Director appointed

Sanofi joins Open Targets

Promega joins EMBL’s Corporate Partnership Programme

EMBLetc.

Read the latest Issues of our magazine - EMBLetc.

Issue 97, Summer 2021

Issue 96, Winter 2020/21

drug discovery

EMBLetc.

Read the latest Issues of our magazine - EMBLetc.

Issue 97, Summer 2021

Issue 96, Winter 2020/21

Subscribe to our monthly e-newsletter

Newsletter archive

For press

Follow us